Walter J. Urba

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A tailored <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> as a potent tumor suppressor of soft tissue sarcoma

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-05

• 163 Unveiling the non-canonical dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC) using mass spectrometry and watchmaker total RNA-Seq

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338

  The Journal of Immunology · 2025-11-01 · 1 citations

• Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report 3277

  The Journal of Immunology · 2025-11-01

• 636 Addition of GITR agonist to a dark matter cancer vaccine and anti-PD-1 increases regulatory T cell numbers without appearing to impact therapeutic efficacy

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Abstract 6707: Direct <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> and <i>FAT1</i> as potent tumor suppressors in sarcomagenesis

  Cancer Research · 2025-04-21

• Abstract A025: Direct <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> and <i>FAT1</i> as potent tumor suppressors in sarcomagenesis

  Cancer Research · 2025-03-11

• Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System

  JCO Oncology Practice · 2024-11-01 · 9 citations

• 1481 Off-the-shelf dark matter immunotherapy in head &amp; neck cancer: mechanistic insights and clinical efficacy

  2024-11-01 · 1 citations

• 156 Dark immunopeptidome of head and neck squamous cell carcinoma in serial cell lines from a single patient during multimodality treatment time-course

  Regular and Young Investigator Award Abstracts · 2024-11-01

• Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system

  ESMO Real World Data and Digital Oncology · 2024-07-25 · 3 citations